Origionally posted on AdviNOW Medical’s website: https://advinow.com/advinow-featured-in-gartner-hype-cycle-for-digital-clinical-encounters-for-fourth-consecutive-year/
We are thrilled to announce that AdviNOW has been recognized in the Gartner Hype Cycle for Digital Clinical Encounters for the fourth year in a row. This continued acknowledgment underscores our commitment to innovation and leadership in the healthcare technology sector.
Digital Clinical Encounters: Transforming Healthcare Delivery
The Gartner Hype Cycle highlights Digital Clinical Encounters as a transformational technology with the potential to reshape healthcare delivery. These semiautomated patient interactions leverage clinical protocols, algorithms, and AI to streamline history-taking, triage, diagnosis, prescribing, and documentation processes.
Key Highlights from the Gartner Analysis:
- Benefit Rating: Transformational
The Impact of Digital Clinical Encounters
According to Gartner, Digital Clinical Encounters are poised to address critical challenges in healthcare, including:
- Improving clinician efficiency and reducing burnout
- Enhancing patient access to care
- Addressing clinical staffing shortages
- Increasing both patient and clinician satisfaction
AdviNOW’s Role in Shaping the Future
As a recognized vendor in this space, AdviNOW is at the forefront of developing solutions that align with Gartner’s vision for Digital Clinical Encounters. Our technology is designed to:
- Automate key steps in the care delivery process
- Leverage AI and machine learning for improved decision-making
- Seamlessly integrate with existing healthcare IT infrastructures
- Enhance the patient experience while optimizing clinical workflows
Looking Ahead
The healthcare industry is at a pivotal point, with Digital Clinical Encounters playing a crucial role in addressing challenges like an aging population, increasing chronic disease burden, and clinician shortages. AdviNOW remains committed to driving innovation in this space, continually refining our solutions to meet the evolving needs of healthcare providers and patients alike.
We are honored by this continued recognition from Gartner and are excited about the future of Digital Clinical Encounters. As we move forward, we remain dedicated to our mission of revolutionizing healthcare delivery through cutting-edge AI and automation technologies.
For more information about AdviNOW’s Digital Clinical Encounter solutions and how they can benefit your healthcare organization, please visit our website at www.advinow.com or contact our sales team at sales@advinow.com.
Click here to view Gartner’s Hype Cycle for Digital Care Delivery Including Virtual Care, 2024
[Note: Gartner is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.]
are thrilled to introduce these new products as part of our CRISPR Analytics Platform. Gene editing is a clinical reality, proving its value, and every year more companies develop CRISPR programs, as we’ve seen with our customers. Our tools will increase the pace of therapeutic development enabling our customers to more rapidly meet their patients’ needs. These advancements are a testament to CRISPR QC’s commitment to scientific progress, and a strategic move solidifying its position in the market.”
About the CRISPR Analytics Platform
CRISPR QC’s CRISPR Analytics Platform offers unparalleled, interrogative measurements and analysis of CRISPR activity, enabling scientists and researchers to optimize gene editing outcomes and ensure the highest levels of quality control. Built on the company’s proprietary CRISPR-Chip technology, the platform allows for direct, real-time measurement of CRISPR activity, providing critical insights at every stage of the gene editing process.